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CHAPTER 1

INTRODUCTION
1.1

B cell as a source of antigen-specific humoral immunity
Immunity has been known to be adaptive or innate. The adaptive immunity

comes from the cellular or humoral immune responses. The cellular immune response
is conferred by the cytotoxic T lymphocytes and a humoral immune response is controlled by the B lymphocytes which produce antibodies against specific antigens. Most
of these antibodies are produced by the progenies of B cells called the plasma cells
(Victora et al., 2010) The other progeny of B cell is memory B cell which helps in activating the antibody mediated immune response rather quickly in case of recurring
infections. The B cells before being a part of the humoral immune response undergo
different developmental stages and provide distinct functions at diverse locations. The
B cells after being generated in the bone marrow go to the spleen where they are further selected and they fully mature. These mature B cells are found in the marginal
zone (MZ) of the spleen and in the primary follicle, the B cells in the MZ stay in the
spleen and act against the blood-borne pathogens.
However, the B cells in the primary follicle travel around in the secondary lymphoid organs and act upon the antigen that is detected which activates the humoral
immune response by generating antibodies against the specific antigen (Sunshine et
al. 2004). When B cells encounter an antigen, they migrate to the border in between
the follicle and T cell zone. This is where the antigenic peptides get presented to the
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MHC class II molecules on T helper cells (CD4+ cells). The antigen-specific B cells then
receive these signals from the T helper cells and start proliferating and undergo isotype switching. While some of the B cell progeny that gets activated become the extrafollicular antibody-secreting plasma cells, many get involved in forming germinal
centers where they generate memory B cells and long-lived plasma cells (Manz et al.
2002). The T cells recognize the antigens in their digested peptide form in a molecular
complex with MHCs. Whereas B cells detect the antigen in their native form. It is
known that the naïve B cells are able to interact with soluble antigens and to get
activated (Pupovac and Good-Jacobson 2017). B cells that initially detect these antigens have receptors on it called the B-cell receptors (BCRs). This receptor is known to
activate a cascade of signals for the antigen presentation to T cells. On plasma membrane of a mature naïve B cell, BCRs containing either of two isotypes, IgM and IgD,
are expressed. These B cells would undergo isotype switching at the germinal center
as part of the complex germinal center reactions (Treanor 2012).

1.2

Germinal center in the secondary lymphoid organs
The germinal center first described by Walther Flemming in 1884, now has

been known to be a microenvironment where the B cells grow in a follicle and proliferate and undergo somatic hypermutation to be later divided into antigen-specific effector B cells. These germinal centers have been detected in the secondary lymphoid
tissues like the lymph nodes and spleen. This is where the B cell follicles form or activate in response to a T cell dependent antigenic response (Meyer-Hermann et al.
2012). This response is generated as a result of clustering of the B cell follicles and
the antigen-specific T cells from T cell zones. The B cells that get activated by this
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response gets to adopt two fates, they either go to the extrafollicular sites and proliferate and differentiate as short-lived plasma cells which secrete the antibody or they
move to the B cell follicles that are known to establish the germinal center (GC) (Allen,
Okada, and Cyster, August 2007). They enter a network of follicular dendritic cells
(FDCs) which are stromal cells with multiple processes along with capturing antigens
to present to the B cells.
The GC is known to begin its formation in a few days once B cells encounter
the specific antigens (Mesin, Ersching, and Victora 2016). They are known to reappear
after the interaction with the same antigen, the size of this GC is known to reduce
with recurring immunization. GCs are known to be associated with a series of functions like the B cell somatic hypermutation, B cell selection based on antigen-specific
signals, clonal B cell expansion and differentiation of these B cells to memory B cells
or long-lived plasma cells. These memory B cells have been known to proliferate in
the presence of FDCs holding the antigen as well. These memory B cells are present
in small numbers after the infection and can give rise to antibodies to recurring antigen without forming a GC.
Affinity maturation has been known to occur due to the somatic hypermutations that happen in the variable region genes in an antibody secreting plasma cell.
The proof that it happens in the GC was brought about when they noticed minimal
somatic mutations in the short-lived plasma cells which are extrafollicular. On the
other hand, the frequency of this somatic hypermutation was seen to be higher in the
GC B cells suggesting its activation in the GC. Another finding in this area has been
that, the selected GCs were from a single clone which was pointing towards the fact
that the affinity maturation happens within a cascade of steps including clonal
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proliferation, somatic hypermutation and then selection. This also leads to the fact
that since memory B cells and long-lived plasma cells are formed within the GC they
undergo a good amount of somatic hypermutation and clonal selection (Allen, Okada,
and Cyster, August 2007.)

Figure 1.1 Schematic diagram of a fully formed germinal center. The GC forms
in a secondary lymphoid organ in response to a B cell encounter to an antigen. The B
cells differentiate into the memory B cells or plasma cells based on their fate and the
plasma cells, in turn, produce antibodies which fight against the antigen. Tfh cell and
follicular dendritic cells provide adequate signals and receptors for the B cells growth
and differentiation.
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1.3

Critical biological signals to B cells
B cells in the GC need critical biological signals from the surrounding and cer-

tain factors which help them undergo the entire process of selection and maturation.
B cells receive signals from the soluble antigen directly which plays a major role in
the affinity maturation and its selection and proliferation. The signals coming from
the follicular helper T (Tfh) cells are also responsible for the high affinity and selection. The interaction between the Tfh cells and B cells have many co-stimulatory signals like the CD40-CD40L, inducible co-stimulatory ligand (ICOSL)–inducible costimulatory (ICOS), programmed cell death protein ligand 1 (PDL1)–programmed cell
death protein 1 (PD1), and IL-21 receptor (IL-21R)–IL-2 (Figure 1.2). These are known
to favor the somatic hypermutation and isotype class-switch recombination (CSR)
which in the end provide GC dependent memory B cells and long-lived plasma cells
(LLPCs) with high affinity. BAFF (B-Cell Activating Factor) is a critical factor in the
maturation and class switch recombination (CSR). Tfh and B cell interaction has also
been seen expressing high calcium signaling along with IL-4 and IL-21.
CD40L-CD40 interaction between the Tfh and B cell is necessary for GC formation, CSR and somatic hypermutation all of which are necessary to have more affinity to the antigen and thus form long-lived plasma cells and memory B cells
(Natkunam 2007). CD40 engagement with CD40 Ligand has been noticed to perform
adhesion, proliferation for a longer time and differentiation into different B cell subsets, the plasma and memory B cells (Elgueta et al. 2009).CD40L has been known to
be in its homotrimer form in the cell membrane along with it TNF family structural
homology. The 18kDa soluble form fragment of the protein from aa 112-260 is known
to interact with the CD40 receptor both is soluble form and on B cell surface,
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ultimately leading to expansion and B cell proliferation(Mazzei et.al, 1995) . It has
also been proven that Interleukin-4 (IL-4) receptor signaling is another essential part
of the GC responses. CD40L is not only important in the in vivo GC reaction but plays
a critical role in vitro GC B cell culture as well. The cell cultures in vitro have seen to
undergo apoptosis after 24-30 hours if not provided with CD40L signals.

Figure 1.2 A schematic representation of Critical biological signals from the
Tfh cell for the B cell growth and expansion. Multiple signals from different cytokines and proteins are involved in the proper and faster differentiation and expansion of B cells. CD40-CD40L is the major interaction in between the Tfh cell and B
cell which helps the B cells multiply and differentiate. They have been known to dissociate with the ligand in order to move to the dark zone in order to enter the second
cell cycle and undergo somatic hypermutation and division again.
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1.4

Germinal center dynamics
Germinal center as discussed before is a microenvironment which is a result of

B cell detecting the antigen inside the secondary lymphoid organs. As they mature
from the primary to secondary follicle the two separate compartments become evident
and they are now referred to as dark and light zones based on the histological appearance. The light zone as the name suggests is lighter in appearance and has fewer B
cells and have more FDCs and T helper cells interacting with the B cells which provide
critical signals for the B cell growth and maturation. Dark zone, on the other hand, is
darker and dense in appearance and has more B cells in it which are undergoing division and proliferation (Allen, Okada, and Cyster, August 2007).
GCs behave in a very dynamic way by performing a cyclic re-entry from the
dark zone to light zone and vice-versa. This is a controlled mechanism and requires
upregulation and downregulation of many genes and proteins. It is known that the B
cells proliferate in the dark zone and undergo affinity maturation in the light zone.
The cells have been seen to undergo at least two cycles of division before they undergo
apoptosis. This division continues the cyclic re-entry from light to dark zone. Somatic
hypermutation an important feature of the GC B cells is a result of the replication and
hence is believed to happen in the dark zone since the mitosis and replication of cell
cycle happens in the dark zone (Hauser et al. 2007). Once the cells divide and undergo
somatic hypermutation, they are ready to move to the light zone which happens by
the downregulation of CXCR4 (CD184), a chemokine receptor that is seen highly upregulated in the dark zone and is known to play a role in the B cell development and
maturation. This CXCR4 (CD184) downregulates once it moves to the light zone. The
light zone cells have been seen expressing high CXCR5 and CXCR13 even though they
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are not exclusive for the light zone (Victora et al. 2010). The CXCR4 (CD184) is used
to differentiate between the dark and light zone in Flow Cytometry studies. The movement of the B cells after somatic hypermutation is controlled. Some cells that do not
undergo a favorable mutation undergo apoptosis in the dark zone before they can enter the light zone for further selection. It is a way of filtering the cells that do not have
the affinity to the specific antigen or have the BCR responsible for the same (Stewart
et al. 2018).
The B cells that enter the light zone have the newly formed or mutated BCRs
that have selectivity for the antigen. In the light zone, the cells with the highest affinity get selected and undergo affinity maturation by getting antigen-specific signals
and other B cell development signals from the FDCs and Tfh cells. The cells which do
not get selected go back to the dark zone for the second round of division and undergo
somatic hypermutation. The affinity maturation gives the high-affinity B cells which
get later differentiated into plasma cells which produce the ultimate antibodies
against the antigen or the memory B cells which lay dormant with the receptors until
the antigen enters the body again (Hoffman, Lakkis, and Chalasani 2016).
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Figure 1.3 A schematic representation of B cell Germinal center dynamics.
The GC is the nest for the B cells to grow and differentiate. The dark and light zone
are separated, and the B cells undergo cyclic reentry process where they undergo the
cell cycle division at least twice in the dark zone and get selected for differentiation in
the light zone. The dark zone is known to be low in CD86 and high in CD184 (CXCR4)
expression. The light zone, on the other hand, has high CD86 expression and low
CD184 (CXCR4) expression.

1.5

Artificial methods to present biological signals using magnetic microbeads
The biological signals from the T helper cells and FDCs can be reproduced in

vitro and provided to the B cells for them to proliferate and expand. There have been
many ways in which these signals are provided to the B cells. The soluble CD40L
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signals and other signals like BAFF and IL-4 in the soluble form have been used previously and are important for the B cell growth and maturation in vitro (Roh et al.
2018). It has been known from previous studies that presentation of CD40L using a
crosslink fashion with the help of monoclonal antibodies along with IL-4 provide better proliferation of the B cells in vitro (Banchereau et al. 1989). Crosslinking the
CD40L with a monoclonal is believed to activate the serine/threonine and tyrosine
phosphorylation which is in turn known to allow the B cells to undergo proliferation
and isotype switching (Hollenbaugh et al. 1992). Other methods that have been applied include, presenting the crosslinked CD40L signals on a microbead so that they
are able to mimic the helper cells and follicular dendritic cells and end up linking with
the B cells which help them expand better (Roh et al. 2018).
A derivative of D-biotin, desthio-biotin, helps in achieving the reversible binding of the biotin labeled protein conjugate to avidin or streptavidin derivatives (Huynh
and Wylie 2018). This chemistry of bioconjugation to present the CD40L signals on
the beads in a very controlled manner has proven to give higher expansion in comparison to just the soluble form of presentation (Roh et al. 2018). Since CD40L is the
signal responsible for the B cells growth and maturation and it is also known to be
responsible for the ability of the cells to undergo cyclic reentry from light zone back to
dark zone (Elgueta et al. 2009). B cells also require other signals for the growth, BAFF
and IL-4 are one such kind which is naturally found in soluble form as well and is
supplemented to the cell in vitro via media. Microbead presentation is a controlled
method since the signals can be removed and provided back in the same manner as
the dynamics go in vivo where the cells tend to leave the signals from the light zone
in order to go to the dark zone.
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Figure 1.4 A schematic representation of artificially presenting CD40L signals to the B cells. The scheme depicts the streptavidin coated bead labeled with
desthio-biotinylated anti-HA tag antibody coupled with recombinant HA-tagged
CD40L. This complex can bind to the B cell which has the CD40 receptors.

1.6

Comparing streptavidin-biotin affinity vs streptavidin-desthio-biotin
Avidin-Biotin or Streptavidin-Biotin chemistry have been exploited for many

applications in immunology, affinity chromatography, and many other fields. To select
the best way of artificial presentation of the biological signals, the affinity and reversibility are factors required to be considered. Avidin tends to give non-specific binding
sometimes, which is a result of the presence of sugars and high ph. Streptavidin, on
the other hand, provides more specific binding and can solve the problem of non-specificity. The high affinity and specificity of the streptavidin-biotin system are widely
11

known (Zhang et al. 2009). The system is also compatible with flow cytometry and
electron and even fluorescence microscopy.

As the affinity of the streptavidin to biotin is very high, the bond is very difficult
to break without degrading either of the molecules. In order to make this binding reversible while keeping a moderate affinity towards streptavidin, a variety of derivatives of D-biotins have been developed (Christopoulos 1991). One such modified version is desthio-biotin (Figure 1.5). The streptavidin and biotin are known to have one
of the strongest non-covalent interaction with a Kd (dissociation constant) value of 1015

M and on the other hand streptavidin and desthio-biotin have a Kd of 10-11 M result-

ing from the removed sulphydryl group. This gives the D-biotin an opportunity to compete with the desthio-biotin and take over by replacing and binding to the streptavidin
(Ahlers et al. 1991). These molecules can be attached to various proteins (e.g. antibodies) via various biocompatible chemistry, for example, amine-reactive succinimidyl ester (Figure 1.6).
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Figure 1.5 Comparison of D-biotin (left) and Desthio-biotin (right). The comparison of the chemical structures of D-biotin and desthio-biotin.
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Figure 1.6 Irreversible vs reversible bioconjugation. The difference in the use
of regular D-biotin or desthio-biotin in the reversible bioconjugation. The two comparisons show the difference in the Kd (dissociation constant) values which are 10-15 M
and 10-11 M respectively. This allows the competitive binding to take place in between
D-biotin and desthio-biotin and hence desthio biotinylated proteins can be replaced by
D-biotin.
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1.7

Purpose of the study and hypothesis
Germinal Centers, in general, have been known to be the heart of Humoral

immunity and, play a major role in the formation, and maturation of B cells. This is
where the B cells undergo somatic hypermutation, affinity maturation and selection
to differentiate into plasma cells producing specific antibodies and or into memory B
cells as a backup for the secondary immune response. The general population of the
B cells being formed in the spleen is generally low, this is considered to happen due
to the very high antigen affinity requirements and the random somatic hypermutations which gives a lower positive output of the antigen-specific B cells. This problem
of lower B cell number leads to lower antibodies being formed and hence the antigen
ultimately attacking the body. The problem of low cell numbers is being worked upon
in vitro where researchers have been trying to come up with a way of expanding and
keeping the B cells alive for a longer period and selectively maturing them for a specific antibody.
So far, scientists have successfully expanded the B cells to a million-fold by
using an external fibroblast -based feeder cell line with CD40L and BAFF, which helps
the cells grow and survive and ultimately proliferate (McHeyzer-Williams, Cool, and
McHeyzer-Williams 2000).However, performing an ex vivo GC reaction by mimicking
the germinal center environment ex vivo has not been explored yet. Successful mimicking of the germinal center and continuous B cell proliferation without using the
genetically-modified feeder cell line can be beneficial in creating a cheaper and simpler model to understand the germinal center B cell physiology and use the same to
develop a platform to form drugs and therapeutics, especially for immunocompromised patients.
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Here we hypothesize that mimicking the germinal center microenvironment
by creating an artificial Tfh cell will help provide the necessary CD40L signal to the
B cell using the desthio-biotin-streptavidin affinity complex chemistry to in turn multiply and expand the B cells in vitro like they would in vivo. This mimicking along
with other B cell growth factors in a soluble form will help the B cells expand better
in specificity to an antigen. By using the same chemistry of desthio-botinylation to the
streptavidin antigen-specific B cells can be isolated and used for the generation of
antigen-specific antibodies and multiple other functions, which is otherwise a low outcome process in vivo due to the random somatic hypermutation and selection process.
The in vitro approach to generate the B cells and expand them multiple folds
to be able to use them to create a large pool of B cells that are antigen-specific generating its own antibodies, can provide an opportunity to use them for wide range of
applications like , therapeutics, drug development and immunotherapy to name a few.
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CHAPTER 2

METHODS
2.1

Mice spleen and naïve B cell isolation
The spleen was isolated from C57BL/6J mice and subjected to B cell isolation.

The spleen was crushed on a strainer into a Falcon tube and subjected to centrifugation at 400 g,4 ˚C for 5 minutes after adding 15 ml of 1X PBS into it. The resulting
pellet was later resuspended into 5 ml ACK Lysis Buffer and was incubated for
5minutes at room temperature. After incubation of the resuspension, 20 ml of 1X PBS
was added and the suspension was brought to be centrifuged again at 400 g, 4 ˚C for
5 minutes. The final pellet was resuspended in 5 ml of MACS Buffer. The final resuspended product was brought to a cell strainer again to filter out any final clumps and
was later transferred to a 15 ml tube. The cells were then counted on the hemocytometer.
Based on the cell number isolated MACS (Magnetic assisted cell sorting) B cell
Separation wherein LS Column was used to separate the B cells and the collected cells
were then counted using a Hemocytometer. Finally, a B cell Isolation Kit from Miltenyi was used using negative magnetic sorting the B cells were isolated and was
proceeded to cell culture in a 24/96 well plate.
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2.2

Media and buffer preparation
For a GC B cell culture, RPMI 1640 complete media was used.

2.2.1 RPMI 1640 complete media
A bottle filter made of polystyrene (Corning, 0.22μm pore size) was assembled
in the sterile laminar hood and used for the sterilization of media. FBS (Sigma) and a
vial of Pen/Strep (Gibco) (both kept in minus 20 ˚C) was thawed in a 37 ˚C water bath
for about 30 minutes. FBS (Sigma) and a vial of Pen/Strep (Gibco) (both kept in minus
20 ˚C) was thawed in a 37 ˚C water bath for about 30 minutes. To make a 500 ml of
total media, 435 mL RPMI-1640 Medium (Gibco) was added to the top of the bottle
filter and 0.5 mL β-Mercaptoethanol (5.5 x 10-5 M) was added into the filter. This was
later accompanied by 5 mL of sodium pyruvate (1 mM). 5 mL HEPES buffer (10 mM)
was then added to the filter. And 50 mL 10 % FBS was mixed to the filter, which was
followed by 5 mL Penicillin/Streptomycin (100 units/mL Penicillin and 100 μg/ml
Streptomycin). The filter top was closed, and the vacuum pump was attached and was
turned on for the media to flow through quickly. Once the filtration was complete, the
filter was removed, and the bottle was labeled and stored in 4 ˚C.

2.2.2 MACS buffer
MACS (Magnetic assisted cell sorting) buffer was used to suspend the beads
and the cells for the cell sorting. In a 500 ml flask, 500 ml of 1X PBS was mixed with
2 ml of 0.25 M EDTA (2 mM final concentration) and 2.5 g of BSA (Bovine serum
albumin) (0.5 % final concentration) for 15 minutes on a vortexer. The mixture was
then poured to the corning 0.22 μm pore sized bottle filter made of polystyrene and
passed through. It was stored in 4 ˚C to be used as a buffer for multiple analyses.
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2.3

Preparation of bioconjugated desthio-biotin labeled anti-HA tag antibody
The protocol in the desthio-biotin protein labeling kit (Thermo Fisher Scien-

tific) was followed to first label the anti-HA tag antibody with desthio-biotin. The reaction was done for a small volume of anti-HA tag antibody at 0.5 mg/ml concentration
in 1XPBS buffer. The kit contained the following items for the whole reaction: Desthiobiotin, succinimidyl ester- 200 μg, DMSO (Dimethyl Sulfoxide), reaction tubes, purification resin (10 ml of sedimented resin with a size exclusion of ~30,000 MW), spin
column, collection tubes. 50 μl of anti-HA tag antibody solution at 0.5 mg/ml was
added to a reaction tube which had a stir bar for the proper mixing, to this tube 20 μl
of freshly prepared 1 M sodium bicarbonate solution was added. 40 μl of DMSO was
added to 1 vial of the desthio-biotin succinimidyl ester. The contents were pipetted
properly to ensure proper mixing (this solution was prepared freshly right before its
use). 2 μl of the freshly prepared desthio-biotin (DSBX-Biotin, Thermo) solution was
added to the reaction tube containing antibody and sodium bicarbonate solution mixture while stirring it continuously and were mixed properly. This mixture was kept
on a stirrer for 1.5 hours at room temperature.
To purify the protein out a spin column was taken, and 1 ml of purification
resin was added to it after stirring it properly and was let to settle. Once the resin
settled more resin was added to bring the final volume to ~1.5 ml. This spin column
was placed in the collection tube provided in the kit and was centrifuged at 1100 x g
for 3 minutes in a swinging bucket rotor centrifuge. The buffer accumulated in the
collection tube was discarded. The antibody solution was then added to the center of
the spin column with the purification resin gel bed. After letting it settle for some time
the spin column was placed in the collection tube again and centrifuged at 1100 x g
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for 5minutes in the swinging bucket rotor centrifuge. The collection tube contained
the desthio-biotin labeled anti-HA tag antibody in 70 μl of PBS at 7.2 pH with 2mM
sodium azide and the desthio-biotin that was not conjugated with the antibody was
left in the column. Usually, 80-90 % of protein gets conjugated with the desthio-biotin,
hence, to calculate the concentration of the labeled antibody solution following calculation was used.
𝑚𝑔⁄𝑚𝑙 𝐷𝑆𝐵 − 𝑋 𝑏𝑖𝑜𝑡𝑖𝑛 − 𝑙𝑎𝑏𝑒𝑙𝑒𝑑 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =

2.4

𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑚𝑔 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑥 0.85
𝑚𝐿 𝑖𝑛 𝑐𝑜𝑙𝑙𝑒𝑐𝑡𝑖𝑜𝑛 𝑡𝑢𝑏𝑒

Preparation of streptavidin microbeads labeled with desthio-biotinylated
anti-HA tag antibody
Desthio-biotin-conjugated anti-HA tag antibody was labeled using the dyna-

beads M-280 (Thermo Fisher Scientific) streptavidin. The dynabeads to be used were
washed before coupling with desthio-biotin anti-HA tag antibody using 1X PBS
Buffer. 20 μl of 2 ml dynabeads was taken and transferred to a microcentrifuge tube
and 1 ml of 1X PBS Buffer was added to it and placed on a magnet for 2 minutes. The
supernatant was discarded, and an equal amount of PBS was added back to the Beads.
30 μl of the desthio-biotinylated anti-HA tag antibody was then taken and added to
the beads solution and left for 30 minutes on a rotor. After the incubation, the beads
were taken and kept on the magnetic separator again for 2 minutes. The supernatant
was discarded, and the coupled antibody was washed with 1X PBS containing 0.1 %
BSA four times. The desthio-biotin anti-HA tag antibody coupled streptavidin dynabeads were now resuspended in 10times of the volume of desthio-biotin anti-HA tag
antibody with 1X PBS buffer containing 0.1 % BSA and ready to be used.
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2.5

Loading of HA-tagged CD40L onto streptavidin microbeads labeled with
desthio-biotinylated anti-HA tag antibody
The varying amount of recombinant mouse CD40L with HA tag (from R &D

Systems) was incubated with the streptavidin beads coupled with desthio-biotin-antiHA tag antibody on a tube rotator at 4 ˚C for 30 minutes. The unloaded CD40L was
washed off with one step of washing using 1ml 1X PBS. The magnetic microbeads
were harvested by the magnet and resuspended in 1X PBS.

Figure 2.1 Artificial Tfh mimicking cell complex formation and disintegration. The desthio-biotin biotinylates the anti-HA tag antibody which is later conjugated with CD40L and this complex then gets attached to the streptavidin beads and
is reversible with D-biotin due to the modified form of biotin with a seven-atom spacer.
This complex is used in the germinal center B cell culture to study periodic changes
in the dark and light zone formation with the presence and absence of CD40L signal.
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2.6

Ovalbumin-specific B cell isolation
To effectively isolate antigen-specific cells, ovalbumin (In Vivogen) was used

as the model antigen. DSBX-biotin (desthio-biotin) protein labeling kit (Thermo) was
used to biotinylate the ovalbumin. Once the ovalbumin was labeled with the desthiobiotin, 35 μl (5.89 mg/ml) of desthio-biotinylated ovalbumin solution was added to 20
μl (6-8 x 108 beads/ml) of streptavidin-coated microbeads suspension, and the mixture
was incubated at 4 ˚C for 30 minutes. After washing the beads with 1X PBS once, the
microbeads were harvested using a magnet. The microbeads loaded with ovalbumin
were mixed with the B cells at a ratio of 1:1 bead to cell ratio. For example, 20 μl (6-8
x 108 beads/ml) of bead suspension was added to 12 x 106 B cells and the mixture was
incubated for 30 minutes.
This mixture of B cells and microbeads suspension was brought to the magnet
and the cells that were not specific to the ovalbumin were collected from the supernatant. The ovalbumin-specific B cells were attached to the magnetic microbeads and
harvested on the surface of the microcentrifuge tube near the magnet. To get rid of
the beads from the sorted B cells, the higher affinity of streptavidin towards D-biotin
showing competitive binding was used to replace the complex and detach the microbeads from the B cells. D-biotin in the final 10 mg/ml concentration was able to
replace the desthio-biotinylated OVA from the streptavidin-coated microbeads when
the suspension was kept for 30 minutes along with D-biotin. The detached microbeads
were harvested using the magnet. The final ovalbumin-specific B cells were isolated
from the supernatant and subsequently subjected to immunofluorescence analysis using flow cytometry.
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Figure 2.2 Biotinylation of ovalbumin. A step by step protocol behind the biotinylation of ovalbumin using desthio-biotin. The biotinylated product is then later conjugated to the streptavidin-coated microbeads which can later be used to selectively
isolate antigen (ovalbumin in this case) specific cells.
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Figure 2.3 Ovalbumin specific B cell isolation. Schematic description of the stepby-step protocol to isolate the ovalbumin-specific B cells with the help of desthio-biotinylated ovalbumin and streptavidin beads to attach and separate them selectively
along with D-biotin to remove the magnetic microbeads from the isolated ova specific
B cells.
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2.7

Cell culture
The cells after isolation were cultured in a 96-well tissue culture plate at 105

cells/well. The cells were supplemented with the RPMI complete media prepared in
the lab along with murine recombinant IL-4 (20 ng/ml, Peprotech) and BAFF (10
ng/ml, R & D Systems). The media was replaced and replenished every 3 days. The
conditions with different forms of CD40-C40L (100 ng/ml) ligation methods were
added to the well plates as a triplicate of each condition and is explained in the text.
The cultures were kept for 6-9 days in the CO2 incubator at 37 ˚C.

2.8

Microscopic imaging
Cells were imaged every day on the EVOS FL auto imaging system with the

help of EVOS software for 9 days of cell culture to continuously look for the cell cluster
formation and cell growth and to observe the behavior of the cells and beads when
introduced to the D-biotin. The 96 well plates with cells, was placed on a platform of
the microscope and imaged at 4X and 20X.

2.9

Immunofluorescence analysis
These studies were performed on the attune NxT acoustic focusing cytometer

(Thermo Fisher) and stained with separate antibodies as markers to look at the specific cell population.

2.9.1 Immunofluorescence analysis for B cells
B cell analysis was performed on the flow cytometer, by suspending the cells
in the MACS buffer (PBS supplemented with 0.5 % (w/v) BSA and 2 mM EDTA). Anti
CD16/32 monoclonal antibody was used to minimize the non-specific binding of the
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antibodies on the cell surface receptors and was followed by adding the combination
of antibodies like FITC, PE, PE-Cy7 or APC for markers like CD184 (CXCR4), CD86,
CD38, GL7, IgM and IgG1. Typically, 0.1 ~ 0.5 μg of antibody was used for staining of
approximately 105~107 cells in 100 μl. For the control, the unstained cells were used
and for the compensation setup, 100 μl of MACS Buffer was added to empty FACS
tubes (Fisher Scientific) and 1 drop of compensation beads was added to the tubes
containing the buffer. 0.1-0.5 ug of each antibody per tube was added and mixed
properly. They were incubated for 10-15 minutes at room temperature in dark. They
were later resuspended in 3-4 ml of MACS buffer and centrifuged at 300 g for
5minutes at 4 ˚C. The supernatant was poured off and resuspend in 200-300 μl MACS
buffer. This was taken to the flow cytometer and read before beginning analysis of cell
samples.

2.9.2 Immunofluorescence analysis for the bioconjugated desthio-biotin-anti-HA tag antibody
Mean Fluorescence Intensity was used to look at the binding of the Alexa Fluor
647 (RL-1 panel) conjugated desthio-biotin-Anti-HA tag antibody to the streptavidin
beads. The beads were incubated with the Alexa Flour 647 conjugated Anti-HA tag
antibody for 30 minutes and separated using a magnet. The supernatant was discarded, and the beads were resuspended in MACS buffer and transferred to FACS
tubes. The volume was brought up to 3 ml and was subjected to centrifugation at 300
g for 5 minutes. The supernatant was discarded, and the pellet was dissolved in 300
μl of MACS buffer before taking to the flow cytometer to measure the intensity of the
beads that were conjugated with the biotinylated antibody.
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Figure 2.4 Evaluation of binding and removal of desthio biotinylated antiHA antibody on beads. The step by step protocol of desthio-biotinylation of anti-HA
antibody along with Alexa Flour-647, with conjugation later to microbeads and removal of the desthio-biotinylated protein from beads by competitive binding with Dbiotin.

2.10 Fluorescence analysis using multi-mode reader
A multimode spectroscopic plate reader (BioTek) was used to measure the fluorescence of the AF488 dye-tagged to the desthio-biotinylated BSA. The fluorescence
intensity was measured using excitation and emission filters in the range of 485  15
nm and 530  20 nm, respectively. The biotinylated protein was first conjugated with
AF488 in a ratio of 1:7 of protein to dye. This conjugation was done simultaneously
with the desthio-biotinylation step.
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Serially diluted desthio-biotinylated BSA samples in the range of 0.005 – 0.1
mg/ml were prepared and measured to achieve the standard curve (Figure 2.5).
To quantify the binding and unbinding behaviors of the protein from the streptavidin coated microbeads, the dethio-biotinylated samples with varying protein to
bead mass ratios were incubated with the beads for 30 minutes. Post incubation, the
samples were brought to the magnet to collect the supernatant (300 l) containing the
remaining unbound protein. This solution was then transferred to a 96 well black well
plate to be measured in the multimode plate reader (Biotek Synergy) equipped with
an operating computer with Gen5 software. The fluorescent intensity readings were
converted to the unbound protein concentration using the linear regression result
from the standard curve, giving the total bound protein on the beads.
Similarly, to quantify the amount of retrieved desthio-biotinylated BSA from
the streptavidin beads, D-biotin (10 mg/ml) was added to the desthio-biotinylatedBSA-loaded streptavidin beads and the suspensions were incubated for 1 hour. After
incubation, the samples were brought to the magnet again to collect the supernatant
and was transferred to the 96 well black well plate for analysis using the multi-mode
plate reader. The fluorescent intensity from the samples were converted to total
amount of the retrieved protein using the standard curve.
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Figure 2.5 Calibration curve for quantification of AF488 desthio-biotinylated BSA. A curve of fluorescence intensity measured for serially diluted standard
samples. The linear regression result was used to quantify the amount of BSA bound
to and retrieved from streptavidin coated microbeads.
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CHAPTER 3

RESULTS

3.1

Developed and evaluated the use of a reversible bioconjugation chemistry
The biotinylated protein to bead ratio was first optimized by performing fluo-

rescence tests to understand the maximum binding ability of the biotinylated protein
on beads. Two experiments, one by measuring mean fluorescence intensity and others
by measuring fluorescence based on excitation and emission were performed. Experiment with the anti-HA antibody on beads was tested by immunofluorescence measurement of mean fluorescence intensity using AF647 and a model antigen BSA was
used to measure the fluorescence of the samples using AF647 on a flow cytometer and
with AF 488 on a microplate reader.

3.1.1 Evaluated binding of desthio-biotinylated BSA on beads
To evaluate the binding of the desthio-biotinylated protein, here BSA, various
protein mass per bead mass (w/w) ratios were tested and analyzed on the flow cytometer with the help of AF647 dye conjugation on the desthio-biotinylated BSA. 0.1 %,
0.2 %, 0.5 %, 1.0 %, 2.0 %, 5.0 % and 10.0 % (w/w) desthio-biotinylated BSA mass on
streptavidin-coated microbeads mass were tested after 30 minutes of incubation. The
histogram analysis showed a positive region in comparison to the negative gate by the
unstained beads. The analysis showed multiple discrete peaks all above 95% positive
signal from the beads (Figure 3.1).
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Figure 3.1 Evaluation of binding of desthio-biotinylated BSA-AF647 on streptavidin-coated microbeads. The histogram data for w/w protein mass to bead mass
ratios is a comparison to the unstained beads AF647 was used as the dye to conjugate
with the desthio-biotinylated protein to show the signals.
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Figure 3.2 Single population selection showing discrete peaks. The panel on
the top left shows multiple separate populations of different sizes in the SSC-FSC
region of an unstained bead sample and the panel on the top right shows the peak
from one single bead population. The panel at the bottom left shows the same multiple
separate populations for 0.5 % w/w BSA/bead ratio and the panel corresponding to it
on the bottom right shows the positive single bead population.

32

Figure 3.3 Discrete peaks from one bead population in comparison to the
unstained beads. The histogram analysis for the single bead population for all the
BSA/Bead w/w (%) ratios in comparison to the unstained beads on the top left.
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Figure 3.4 Mean fluorescence intensities of varying w/w BSA /beads ratio
from a single bead population on a flow cytometer. The graph for the mean
fluorescence intensity taken from one discrete bead population showing one discreet
peak in histogram analysis for the range of varying w/w BSA/Bead ratios.

After analysis of the bead in the flow cytometer, multiple separate bead population was noticed (Figure 3.2). This could have been due to either bead clusters
formed or the M-280 Streptavidin coated dynabeads selected had beads with multiple
sizes and surface densities. After careful analysis of single population from the total
bead population, it was noticed that post 1 % of w/w BSA/Beads ratio, the binding
saturates and does not make many changes (Figure 3.4).
Desthio biotinylated BSA samples were loaded based on the maximum surface
densities of the streptavidin on microbeads taken for varying mass ratios of w/w
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protein/ bead ratio. The surface density for 1 % w/w BSA/beads ratio was calculated
to be approximately 6.9 x 104 molecules/μm2.

3.1.2 Evaluated binding and removal of desthio-biotinylated BSA on
beads
To confirm the binding and recovery of the protein using the desthio-biotinylation method, BSA was used as the model antigen and was tested upon at different
dosage of protein binding efficiency and recovery. Fluorescence was measured using
the multimode reader set to measure Alexa Fluor 488 at excitation 485 and emission
set at 530. After testing the range of w/w percentages of protein mass to bead mass
ratios (Figure 3.1), the percentages of binding of BSA tested was 0.5 % w/w and 1 %
w/w respectively on the streptavidin-coated microbeads. A standard curve with fluorescence intensity vs protein concentration was plotted by serially diluting the desthio-biotinylated BSA in the range of 0.005 mg/ml - 0.1 mg/ml (Figure 2.5), to calculate
the bound desthio-biotinylated BSA and recovered desthio-biotinylated BSA after
adding D-biotin. 0.5 % of desthio-biotinylated BSA on beads was able to provide the
highest binding which was about 80 %. The recovery of this bound desthio-biotinylated
BSA from the microbeads was done by mixing the pellet samples in D-biotin (10
mg/ml) and testing the recovered mass in the supernatant. The recovery for the 0.5 %
desthio-biotinylated BSA binding sample was about 56.7 %. The binding and recovery
pattern show that the binding efficiency of the of BSA to the beads was highest in 0.5
% of desthio-biotinylated BSA on beads.
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Figure 3.5 Percentage efficiency of Bound and retrieved BSA. The bar graph
shows for the binding and retrieval of the bound w/w desthio-biotinylated BSA / bead
percentages out of 100 in terms of its overall efficiency. The test was performed once.

3.1.3 Evaluated binding and removal of desthio-biotinylated anti-HA
antibody on beads
To optimize and to see the binding and reversal of the biotinylated antibody
flow cytometry analysis was performed with the help of immunofluorescence using AF
647 (FITC-RL-1 Channel) which was tagged to the biotinylated antibody. The binding
was shown by the AF647 positive channel showing the streptavidin coated beads
bound to the desthio-biotin labeled anti-HA antibody tagged to the AF647 dye. Two
major w/w protein to beads ratios were tested, which are 0.5 % w/w anti-HA antibody
on beads and 1 % w/w anti-HA antibody on beads. The results in the flow cytometry
analysis showed a positive signal of 74 % on 0.5 % w/w anti-HA antibody on beads and
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a 98.1 % on 1 % w/w anti-HA antibody on beads respectively (Figure 3.6). The positive
signals indicate that the beads are bound to the biotinylated protein which in turn is
bound to the AF647 dye.
The retrieval of the biotinylated protein tagged to the dye was done by adding
D-biotin (10 mg/ml) which is known to have a higher affinity towards streptavidin
compared to desthio-biotin. The results after one hour of incubation with D-biotin
showed a reduction in the positive signal of AF647 in comparison to the initial bound
percentage positive signals. Figure 3.6 shows flow cytometry histogram data of the
anti-HA antibody on beads at AF647 + signal for both the 0.5 % and 1 % w/w anti-HA
antibody on beads condition in comparison to the unstained beads used as the negative control. As can be seen with the help of negative control shown as the red region,
with 99.1 % taken as negative, the blue area shows the beads before adding D-biotin
and the orange area shows the beads after adding D-biotin. Before adding the AF647
on anti-HA antibody on beads was AF647 + for both 0.5 % and 1 % as respectively.
The 0.5 % w/w anti-HA antibody on beads condition had a reduced positive
signal (AF647) of 24 % while the 1 % w/w anti-HA antibody on beads condition had a
reduced positive signal (AF647) of 20.5 % (Figure 3.6). This confers that after the
treatment with D-biotin for an hour at high concentrations the desthio-biotin complex
was successfully able to get replaced by the D-biotin and not be conjugated to the
beads anymore. With the information above, the 0.5 % w/w anti-HA antibody on beads
condition would be the best ratio to use for the beads to be able to exactly mimic the
Tfh cell and be able to periodically remove the signal and study the changes in dark
and light zone population.
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Figure 3.6 Dose-dependent binding of desthio biotinylated anti-HA antibody
on beads. The flow cytometry histogram data of the anti-HA antibody on beads at
AF647 + signal for both the 0.5 % and 1 % w/w anti-HA antibody on beads condition
in comparison to the unstained beads used as the negative control. The blue area
shows the beads before adding D-biotin and the orange area shows the beads after
adding D-biotin. Before adding the AF647 on anti-HA antibody on beads was AF647
+ for both 0.5 % and 1 %, respectively.
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Figure 3.7 AF647 Positive population test on 0.5 % w/w and 1 % w/w anti-HA
antibody on beads. A graphical representation of the bead’s population showing the
AF 647+ percentages of the two conditions of 0.5 % and 1 % w/w anti-HA antibody/beads reaction, before and after the treatment with D-biotin.

3.2

Ovalbumin-specific B cell isolation
Once the specific cells were isolated, they were subjected to flow cytometry

analysis (Figure 3.8). First, the B cell population was identified using CD19 and B220
as B-cell specific biomarkers (Figure 3.8, top). Second, a recombinant OVA conjugated
with Alexa Fluor 488 was employed to analyze the three populations, unstained, unsorted, and the OVA-specific population sorted by MACS-assisted with desthio-biotinylated OVA (Figure 3.8, bottom). The unstained, unsorted, and MACS sorted populations showed 0.48 %, 1.02 % and 99.1 % in OVA-FITC-positive gate, respectively.
Results from two independent samples are plotted as a bar graph (Figure 3.9).
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Figure 3.8 The total OVA-FITC positive live B cells in the unsorted and
sorted samples compared to the unstained control. Flow cytometry analysis of
the B cell population using the markers CD19 and B220.The topmost panels show the
B cell population. The three panels below show the unstained control, the wild type
(unsorted) and sorted sample of OVA-FITC positive B cell population.
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a)

b)

Figure 3.9 Summary of the OVA-specific B cell isolation. a) The mean fluorescence intensity of OVA-specific B cells detected in the total cell population of wild type
(unsorted) and ovalbumin-specific (sorted) sample respectively. b) The percentage of
ovalbumin positive population from the flow cytometric analysis in the wild type (unsorted) and ovalbumin-specific (sorted) samples respectively.
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The removal of beads to isolate the pure ovalbumin specific B cells was performed by using the D-biotin which would replace desthio-biotin-ovalbumin due to the
higher affinity it possesses. The removal and reduction in the bead percentage over
the cell percentage are shown in the graph (Figure 3.10). The results show a reduction
in the total beads present with magnetic sorting remove the beads from the cell suspension. The initial bead to cell ratio taken was 1:1 for the total isolated B cells. The
flow cytometry analysis of the unsorted sample showed 42.4% of the total population
as the microbeads. After sorting, the total bead percentage to the total ovalbuminspecific B cell population was 11% (Figure 3.10), since spleen has 0.05 % of antigenspecific B cells out of total B cells. This gave us a 10,000-fold beads reduction from the
initial bead to cell ratio taken, leaving minimal beads to a cell in the suspension with
minimal or no chances of cytotoxicity from the microbeads.
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Figure 3.10 Beads to cell ratio. The flow cytometric panel for the beads to cell population percentages before and after sorting them. The graphical data of ratios of bead
to a cell before and after sorting. Two sorted samples were taken to get the mean data.
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3.3

Mimicking germinal center B cell dynamics
Germinal center formation studies were performed by growing the isolated B

cell culture up to 9 days respectively. The cell culture was provided with adequate
growth signals and factors required for the germinal center formation and studied
every day by imaging and flow cytometry. The different conditions applied were based
on the approach the CD40L signal was provided to the B cell culture and those included, i.) soluble CD40L throughout the culture period ii.) CD40L on pierce anti-HA
magnetic beads (irreversible) throughout the culture period iii.) CD40L on reversible
bioconjugate (desthio-biotin HA-tag antibody) streptavidin magnetic beads for periodically presenting and removing the signals (Figure 3.11). The dosage of the first two
conditions were optimized and taken from a previous study (Roh et al. 2018). Where
CD40L dose was maintained at 100 ng/ml of cell culture.
The GC formation was seen starting from day 2 in the microscope where clear
and healthy cell clusters were seen. All the cells under the three conditions were split
equally on days 3 and 6 and resuspended with fresh media and fresh signals of IL-4
and BAFF supplemented through the media. The beads presented to the B cells temporarily was maintained at a uniform time period of 24 hours starting from day 1
through 9 of the cell cultures.
The GC formation was analyzed each day using immunofluorescence analysis
which provided the Dark zone and Light zone formation and behavior throughout the
cell culture where CD184 and CD86 monoclonal antibodies were used to analyze the
dark and light zones respectively (Figure 3.12).
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Figure 3.11 Timeline to study germinal center B cell dynamics. The timeline
for the 9-day culture and the variance in the three conditions to study the dark and
light zone formation and dynamics over the 0-9 days, the analysis of which was done
on the Flow cytometer every day starting day 0 until day 9.
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Figure 3.12 Flow cytometry analysis for Dark and Light zone variation over
the cell culture period. DZ and LZ represent the dark and light zone, respectively.
CD184 (CXCR4)

hi

CD86

low

and CD184

low

CD86

hi

gates were used for evaluation of

DZ and LZ populations, respectively. The overall change in the DZ and LZ population
over the 9-day culture in the four conditions were shown.
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The cells were also tested for the isotype switching to see if the somatic hypermutation
occurred for the cells to be able to get selected. The B cells in all the conditions were
analyzed in the flow cytometer everyday starting day 0 till day 9. The markers for
isotype switching used were IgM and IgG1. The cells have been known to undergo
switching and somatic hypermutation once they mature and undergo selection. The
panels for all the three conditions were laid out and the difference in the pattern and
shift in the population from IgM to IgG1 was analyzed. This was significant on days
2,4 and 9. (Figure 3.13). While the condition with CD40L on pierce magnetic beads
coated with anti-HA antibody gave highest class switch even on day 2 of the cell culture, the soluble CD40L presentation gave almost no switching in the population over
the 9 days of culture. The condition with CD40L on biotinylated anti-HA antibody
microbeads presented and removed gave very minor change towards day4 and slightly
visible change by day 9. (Figure 3.13).
The images were taken on each day of the cell culture showing the formation
of cell clusters and dissociation using the D-biotin. The three different conditions did
show a good cell proliferation and the condition with periodic presentation and removal of the CD40L signals could be seen clearly attached to the beads and away from
the beads in respective cases. (Figure 3.14). Even though the cells CD40L on pierce
beads could be seen dying towards day 6, the cells in soluble and CD40L on biotinylated beads condition could be seen thriving till day 9. (Figure 3.16)
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Figure 3.13 Flow cytometry analysis of Isotype switching recombination. The
flow cytometric panel for the switch percentage of the live B cell population. X and Y
axes are IgG1 and IgM respectively. B cells undergo switching from IgM to IgG1 once
they are in the germinal center dynamics and to get selected for affinity-based maturation.
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Soluble CD40L

CD40L on irreversible beads

On/off CD40L on reversible beads

CD40L on reversible beads

Figure 3.14 Microscopic images of the artificial complex on day 3. Bright
field microscopic images on day 3 culture images in different conditions. The biotinylated beads have taken off from the culture using D-biotin and magnetic removal.
The other condition with beads present and soluble CD40L.All images are at 20X
(200μm).
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Soluble CD40L

CD40L on irreversible beads

CD40L on reversible beads

On/off CD40L on reversible beads

Figure 3.15 Microscopic images of an artificial complex on day 4. The bright
field microscopic images above show the growth in the size of the cluster on day 4 and
the difference in all the conditions. All images are at 20X (200 μm).
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CD40L on irreversible beads

Soluble CD40L

CD40L on reversible beads

On/off CD40L on reversible beads

Figure 3.16 Microscopic images of the artificial complex on day 9. The
bright field microscopic images show the cells by day 9 in all the conditions. The
cluster can be seen showing a healthy live population in the soluble and periodic
signals conditions. All images are at 20X (200μm).
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CHAPTER 4

DISCUSSION & CONCLUSION

4.1

Developed and evaluated the use of a reversible bioconjugation chemistry
Desthio-biotin provides reversible bioconjugation which helps it attach to the

avidin and streptavidin in a way that it can be replaced with a biotin form having
stronger affinity using competitive binding (Figure 1.6) (Ahlers et al. 1991). To identify the ideal binding efficiency and to understand the exact conditions needed to treat
the complex with D-biotin for reversible bioconjugation, the experiments were performed using different w/w protein to bead ratios. The discrete peaks from the histogram data may signify differently sized beads or just separated bead clusters. The
ideal two conditions were selected to be 0.5 % and 1 % (Figure 3.1) for the further
studies using BSA and anti-HA antibody. From this study, the maximum loading efficiency (desthio-biotinylated proteins to streptavidin beads), as well as the retrieval
(reversible recovery) behavior of desthio-biotinylated proteins from the streptavidin
upon addition of D-biotin was evaluated.

4.2

Ovalbumin-specific B cell isolation
Isolating an antigen-specific B cell purely has been a tedious work because of

the low antigen-specific B cells (0.05 %) out of the very low B cell population in general
(McHeyzer-Williams et al. 2000). The protocol explained above in the results not only
helps isolate the specific cells but also gives a quantitatively good number for it to be
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able to multiply and divide further in vitro. The Ovalbumin specific sample isolated
seems to have a very good percentage of the antigen-specific cells. The beads removal
process from the antigen-specific B cells after sorting, was 10,000 folds. Further tests
can be run on the sample by prolonging the incubation of the samples with D-biotin
longer than 45 minutes which was initially followed to achieve complete 100 % removal of the beads.
The somatic hypermutation that occurs during the dark zone cell proliferation
is completely random and has been a great area of focus for many years now
(Dominguez-Sola et al. 2015). It has been known that if the cells have the antigenspecific signals, the B cells get selected to be of the specific type and hence differentiate to provide the antibodies to the same antigen. (Dufaud, McHeyzer-Williams, and
McHeyzer-Williams 2017). If the cells that already are antigen-specific undergo somatic hypermutation their chances of differentiating as the same is high which could
provide a better expansion of the antigen-specific B cells in vitro.

4.3

Mimicking germinal center B cell dynamics in vitro
The controlled back and forth movement of the B cells from the dark zone to

light zone and vice versa in vitro has not been performed yet (Ersching et al. 2017).
Being able to understand the dynamics and to be able to replicate the same in vitro
can open the paths to many breakthroughs. The use of the controlled periodic CD40L
signals to the B cells is speculated to mimic the same mechanism occurring in vivo
naturally where the cells are believed to undergo a cyclic reentry from dark to light
zone and complete their cell cycle at least twice before they wear out and die (Stewart
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et al. 2018). The mechanism of the cyclic reentry of the B cells from the light zone
where they are in contact to the Tfh cells providing the CD40L signals and they lose
the contact to go back to the dark zone where they divide and undergo somatic hypermutation again to be selected and finally differentiate into either a plasma cell or a
memory B cell (Ersching et al. 2017).
The 9-day culture showed a significant change in the dark and light zone populations in all the conditions however the population showed a reversal in dark to
light zone and back to dark zone towards the late 8th day in the controlled CD40L
signal on surface presentation and retrieval condition. However, this may not have
happened early due to incomplete activation or removal of the surface for the signals
which may have stopped the cells from shifting completely from the dark to light
zones.
The isotype switching that was noticed in the condition with the CD40L on the
pierce irreversible beads starting day 2 itself as has been noticed before (Roh et al.
2018) but was not seen to be as successful in the CD40L on biotinylated reversible
beads condition. This would have been due the possibility that the condition was not
successful in delivering itself on the beads but rather ended up losing the signals from
the surface of the bead and acted like a soluble CD40L condition and the cells did not
receive the signals as well as the condition where the beads were providing it in a
controlled manner. The overall shift from the dark to light zone and back needs to be
optimized with the help of adjusting the conditions and retrieving the signal completely just at the right time and provide it to them again. This may help the cells
behave the exact same way as they would in vitro.
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4.4

Future work
The germinal center is a complex system. Mimicking the full induction of com-

plex germinal center reactions has not been performed by far. The work presented in
this thesis is providing a fundamental technology that will eventually serve as components in the design of artificial germinal center.
One of the exciting results from the thesis is the successful isolation of antigenspecific B cells using rapid and affordable MACS-based method. As the antigen-specific B cells within the germinal center, particularly in the light zone, are activated by
both BCR and CD40 signals, the immediate next step to explore would be to perform
artificial germinal center reaction for the antigen-specific B cells with presentations
of both antigen and CD40L presentation.
Among many features of the complex germinal center, the zonal structure (DZ
and LZ) and the cyclic reentry of activated B cells and the affinity maturation has
never been recapitulated in vitro. In this thesis, the reversible bioconjugation method
was employed to artificially mimic the temporally controlled provision of surface
bound CD40L signals to the germinal center B cells. However, the result showed only
moderate difference from the control groups. The frequency and duration of surface
bound CD40L could be further optimized. Another intriguing observation is the stark
difference in isotype switching between the CD40L presented on anti-HA antibodycoated beads and the desthio-biotinylated CD40L presented on the streptavidin coated
beads. This stark difference could originate from multiple factors, such as difference
in bead diameter, surface density, and the flexibility and length of the linkers. More
careful studies in these parameters will provide further insights on the artificial
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presentation of biological ligands and resulting difference in quality and quantity of
biological signals.
The artificial germinal center B cells cultured with desthio-biotinylated antiHA antibody with temporal provision of surface-bound CD40L signals showed a minimal isotype switching to IgG1. However, most of the cells become IgM negative by
Day 9. This could originate from switching of isotype to other subtypes of IgG, or IgA
or IgE, which needs further investigation. It is possible that the B cells differentiated
to long-lived plasma cells that lose the expression of membrane immunoglobulin receptors. A flow cytometry experiments using plasma-cell markers such as CD138, or
intracellular immunoglobulin staining would provide the answer to this intriguing
hypothesis.

4.5

Conclusion
The study shows the use of desthio-biotinylated proteins with a dose-depend-

ent binding to streptavidin-coated magnetic microbeads up to about 1 % (w/w) proteins/bead ratio. Desthio-biotinylated anti-HA antibody could be reversibly detached
from streptavidin-coated microbeads by incubation with D-biotin. After magneticbead-based sorting with reversible bioconjugation, B cell population showed 99 % positive ova-specific cells. MACS combined with reversible bioconjugation enabled sorting
of antigen-specific B cells with a minimal amount (approx. 10,000-fold reduction) of
residual magnetic beads in culture. While the dark zone population increased over the
9-day culture period with all tested CD40L presentations, the condition with on-andoff surface-bound CD40L presentation modestly increased light zone population by
day 9. The on-and-off surface-bound CD40L presentation induced a modest isotype
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switching to IgG1, and a loss of IgM in majority B cells by day 9. The reversible bioconjugation methods presented in this thesis can ultimately be useful to recapitulate
the full array of germinal center reactions ex vivo to produce functional antigen-specific effector B cells for a novel cellular immunotherapy.
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